We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYXI
2526
DELISTED
Zynex
ZYXI
| $478K | ﹤0.01% |
52,720
+1,142
| +2% | +$12.7K |
|
2527
Akebia Therapeutics
AKBA
$252M
| $477K | ﹤0.01% |
211,115
+805
| +0.4% | +$2.19K |
|
|
TRUE
2528
DELISTED
TrueCar
TRUE
| $477K | ﹤0.01% |
140,262
-4,433
| -3% | -$16.9K |
|
2529
Alto Ingredients
ALTO
$340M
| $476K | ﹤0.01% |
98,934
-688
| -0.7% | -$3.61K |
|
2530
Geron
GERN
$949M
| $474K | ﹤0.01% |
388,853
-2,454
| -0.6% | -$3.52K |
|
2531
First Bancorp
FNLC
$399M
| $473K | ﹤0.01% |
15,056
-13
| -0.1% | -$395 |
|
2532
Cullinan Oncology
CGEM
$1.14B
| $472K | ﹤0.01% |
30,600
-425
| -1% | -$8.48K |
|
2533
Accuray
ARAY
$34M
| $470K | ﹤0.01% |
98,480
-1,514
| -2% | -$7.3K |
|
2534
Greif Class B
GEF.B
$4.21B
| $470K | ﹤0.01% |
7,861
-308
| -4% | -$19.8K |
|
2535
Mid Penn Bancorp
MPB
$952M
| $469K | ﹤0.01% |
14,763
+3,752
| +34% | +$111K |
|
2536
OneWater Marine
ONEW
$201M
| $468K | ﹤0.01% |
7,672
+16
| +0.2% | +$782 |
|
2537
Edgewise Therapeutics
EWTX
$4.73B
| $466K | ﹤0.01% |
+30,511
| New | +$549K |
|
|
AUD
2538
DELISTED
Audacy, Inc.
AUD
| $466K | ﹤0.01% |
181,453
-1,233
| -0.7% | -$3.8K |
|
2539
Home Bancorp
HBCP
$566M
| $465K | ﹤0.01% |
11,198
-115
| -1% | -$4.72K |
|
|
RUBY
2540
DELISTED
Rubius Therapeutics, Inc
RUBY
| $465K | ﹤0.01% |
48,021
-10,662
| -18% | -$148K |
|
2541
Lifestance Health
LFST
$4.14B
| $462K | ﹤0.01% |
48,491
+472
| +1% | +$5K |
|
|
SMMF
2542
DELISTED
Summit Financial Group, Inc.
SMMF
| $462K | ﹤0.01% |
16,845
-440
| -3% | -$11.6K |
|
|
EGLE
2543
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $462K | ﹤0.01% |
10,157
+320
| +3% | +$13.6K |
|
2544
Identive
INVE
$61.9M
| $461K | ﹤0.01% |
16,390
+1,437
| +10% | +$31.6K |
|
2545
American Outdoor Brands
AOUT
$157M
| $458K | ﹤0.01% |
22,963
-32
| -0.1% | -$719 |
|
2546
Omeros
OMER
$959M
| $458K | ﹤0.01% |
71,195
-1,161
| -2% | -$8.42K |
|
2547
Dyne Therapeutics
DYN
$4.9B
| $453K | ﹤0.01% |
38,105
-285
| -0.7% | -$4K |
|
2548
Alkami Technology
ALKT
$2.11B
| $452K | ﹤0.01% |
+22,524
| New | +$577K |
|
2549
Funko
FNKO
$328M
| $452K | ﹤0.01% |
24,051
-94
| -0.4% | -$1.67K |
|
2550
Transmedics
TMDX
$2.91B
| $452K | ﹤0.01% |
23,584
-371
| -2% | -$9.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.